Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
about
Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissueMetastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines.Polyamines and cancer: implications for chemotherapy and chemopreventionDifluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 inductionPolyamines and nonmelanoma skin cancer.Association between the ornithine decarboxylase G316A polymorphism and breast cancer survival.Spermine synthase overexpression in vivo does not increase susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis.Animal disease models generated by genetic engineering of polyamine metabolism.S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion.Current status of the polyamine research fieldThe TCA cycle transferase DLST is important for MYC-mediated leukemogenesis.Mammalian polyamine metabolism and functionTransgenic animals modelling polyamine metabolism-related diseases.A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells.Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.Molecular mechanisms of mouse skin tumor promotion.Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis.Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC.
P2860
Q21132372-450602AA-62A4-4787-BFA8-01651231519AQ24813688-C69362F4-A38E-4A57-A7BE-2906E09D882AQ26783914-0306E75E-0C8E-4A68-92E2-27AD2CF3002BQ26864516-39F909AC-1414-4896-9178-DA5A4AA6210DQ28477296-E4339A7C-1DA8-4F96-9A18-AE4EFA7FA676Q34603550-30561CA3-4D37-48CC-A74A-A1F46A0A83E4Q35803819-C880438E-26DA-49AA-B313-A81108046D30Q35925417-D3A03740-AE93-4846-9DDC-942353DAA8FDQ36346501-705A6BA8-6322-461E-923E-B2F62BCFB488Q36401976-62C2AE25-86E8-47D9-9976-72F155221181Q36838564-4FE6025A-AD3D-4A1A-8CD4-04DB5F9596C1Q36957835-A5057805-6509-46D2-B2D4-3945C10DF43DQ37365983-7538C16D-6127-4F7B-8A21-CAA27C6F75A3Q37679991-2B64920B-4F49-4AFD-90BA-1C86ED31BA8AQ37681196-E7C6194A-8DB7-4D59-B180-967F34667D2CQ38474358-5EED32D4-FF9D-41DC-9F49-BD975A840BBCQ42589687-CBFF73D9-6474-4A67-B97F-4C79DDA0BA4CQ46884912-D2EE3CEC-9F70-4783-BA43-EFBBB5D37A2BQ47613853-0848B46F-7310-4C86-B37B-9D6719399CA3
P2860
Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
@en
Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
@nl
type
label
Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
@en
Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
@nl
prefLabel
Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
@en
Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
@nl
P2093
P1433
P1476
Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
@en
P2093
John L Cleveland
Thomas G O'Brien
Yongjun Guo
P304
P356
10.1158/0008-5472.CAN-04-3244
P407
P577
2005-02-01T00:00:00Z